MedTrace Logo

Pharmacokinetics of Misoprostol With Titrated Oral Administration

NCT01271257 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-01-28

No results posted yet for this study

Summary

The AUC240, AUC360, and AUC480 of titrated oral misoprostol are greater than traditional oral misoprostol.

Conditions

  • Hypotonic; Labor

Interventions

DRUG

Misoprostol

20 microgram PO per hour for 8 doses or 80 microgram PO per 4 hours for 2 doses

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Shi-Yann Cheng, M.D. · China Medical University Beigang Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Taiwan

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01271257 on ClinicalTrials.gov